Breast cancer vaccine update from Cleveland Clinic

Breast cancer vaccine update from Cleveland Clinic: ‘A new era’
A breast cancer vaccine could be closer to reality, according to Cleveland Clinic, as its researchers have announced some encouraging results. Researchers and doctors weigh in.
New vaccine shows promise for patients with aggressive breast cancer
An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests.
Wash U vaccine trial shows promising data in preventing breast cancer recurrence
A groundbreaking treatment has been announced for women with an extremely aggressive form of breast cancer. Siteman Cancer Center just released the results of a clinical trial showing a new vaccine that is preventing cancer from returning.
A Clinical Trial Found an Effective Vaccine for Aggressive Breast Cancer
An experimental vaccine teaching patients’ immune systems to identify and attack cancer cells could help women diagnosed with triple-negative breast cancer.
New vaccine shows promise in treating aggresive form of breast cancer
A trial of the vaccine showed it to be "well-tolerated" and to stimulate the immune system. The post New vaccine shows promise in treating aggresive form of breast cancer appeared first on Talker.
Neoantigen DNA vaccine shows promise against aggressive breast cancer in clinical trial
A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors. Conducted at Washington University School of Medicine in St.
Triple negative breast cancer vaccine shows promising results
New research suggests an experimental vaccine could provide new hope for women diagnosed with an aggressive, hard-to-treat form of breast cancer. This vaccine is effective against triple-negative breast cancer,
Cleveland Clinic making progress in preventative breast cancer vaccine
The Cleveland Clinic is seeing positive results in their preventive cancer vaccine study that could prevent the most aggressive form of breast cancer.
Researchers announce updated findings in preventive breast cancer vaccine study
Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.
Cleveland Clinic announces updated findings in preventive breast cancer vaccine study
Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.
Breast cancer break through as new vaccine shows 'promise' in treating aggressive form
Researchers say the results mark the first time a vaccine - known as a neoantigen DNA vaccine - has shown such positive results in a clinical trial.
News Medical on MSN12h
New vaccine shows potential in preventing recurrence of triple-negative breast cancer
A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.
Anixa Biosciences Reports Promising Phase 1 Vaccine Results
Anixa Biosciences ( (ANIX) ) has provided an announcement. Anixa Biosciences, in collaboration with Cleveland Clinic, unveiled promising ...